Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).

× No keyword cloud information.

29 in total

1. Incidental finding of monoclonal gammopathy in blood donors: a follow-up study.

Authors: Massimo La Raja; Monica Barcobello; Nicola Bet; Paolo Dolfini; Marina Florean; Federica Tomasella; Vincenzo De Angelis; Luca Mascaretti
Journal: Blood Transfus Date: 2012-03-28 Impact factor: 3.443

Review 2. Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myeloma.

Authors: Brendan M Weiss; W Michael Kuehl
Journal: Expert Rev Hematol Date: 2010-04 Impact factor: 2.929

3. Serum free light chain quantitative assays: Dilemma of a biomarker.

Authors: Giovanni Cigliana; Francesca Gulli; Cecilia Napodano; Krizia Pocino; Elena De Santis; Luigi Colacicco; Iole Cordone; Laura Conti; Umberto Basile
Journal: J Clin Lab Anal Date: 2017-04-26 Impact factor: 2.352

Review 4. Precursors to lymphoproliferative malignancies.

Authors: Lynn R Goldin; Mary L McMaster; Neil E Caporaso
Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04 Impact factor: 4.254

5. Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma.

Authors: Emanuele Cencini; Alberto Fabbri; Adele Santoni; Bianca Mecacci; Monica Bocchia
Journal: Indian J Hematol Blood Transfus Date: 2019-12-12 Impact factor: 0.900

6. Clinical interest of bone marrow aspiration in rheumatology: a practice-based observational study of 257 bone marrow aspirations.

Authors: Amélie Loctin; François Bailly; Davy Laroche; Christian Tavernier; Jean-Francis Maillefert; Paul Ornetti
Journal: Clin Rheumatol Date: 2012-10-02 Impact factor: 2.980

7. Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite^™ automated turbidimetric analyzer.

Authors: Marina Garcia-Prat; Gemma Vila-Pijoan; Susana Martos Gutierrez; Guadalupe Gala Yerga; Esther García Guantes; Mónica Martínez-Gallo; Andrea Martín-Nalda; Pere Soler-Palacín; Manuel Hernández-González
Journal: J Clin Lab Anal Date: 2018-03-30 Impact factor: 2.352

Review 8. How I manage monoclonal gammopathy of undetermined significance.

Authors: Ronald S Go; S Vincent Rajkumar
Journal: Blood Date: 2017-11-28 Impact factor: 22.113

9. Educational intervention to optimise serum immunoglobulin test use in Irish primary care: an interrupted time series with segmented regression analysis.

Authors: Sharon L Cadogan; John P Browne; Colin P Bradley; Anthony P Fitzgerald; Mary R Cahill
Journal: Br J Gen Pract Date: 2020-01-30 Impact factor: 5.386

Review 10. What is the significance of monoclonal gammopathy of undetermined significance?

Authors: Catherine Atkin; Alex Richter; Elizabeth Sapey
Journal: Clin Med (Lond) Date: 2018-10 Impact factor: 2.659

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).